Ligand validation:4YZI

RET: RETINAL

RET is a Ligand Of Interest in 4YZI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4YZI_RET_A_401	44%	43%	0.19	0.92	0.79	1.47	-	3	0	0	100%	0.9524
3UG9_RET_A_401	32%	37%	0.24	0.914	0.61	1.93	-	9	1	0	100%	0.9524
7C86_RET_A_401	28%	13%	0.224	0.877	2.8	1.35	6	4	0	0	100%	0.9524
6CSO_RET_A_401	16%	7%	0.313	0.889	0.73	4.28	-	15	0	0	100%	0.9524
7E71_RET_A_401	10%	6%	0.349	0.86	3.07	2.22	4	8	1	0	100%	0.9524
6CSN_RET_A_401	6%	7%	0.348	0.793	0.67	4.24	-	15	0	0	100%	0.9524
7XJE_RET_A_301	99%	7%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
7XJC_RET_A_301	97%	11%	0.067	0.98	1.93	2.43	2	14	0	0	100%	0.7752
7XJD_RET_A_301	97%	11%	0.06	0.972	1.93	2.42	2	14	0	0	100%	0.9524
5ZIN_RET_A_250	96%	7%	0.054	0.964	2.81	2.16	4	10	0	0	100%	0.9524
6TK7_RET_A_301	96%	62%	0.059	0.967	0.85	0.59	1	-	1	0	100%	0.9524

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.